IMP
Process View
positive regulation of triglyceride biosynthetic process
Any process that increases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of triglyceride biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CREBBP | CREB binding protein | 0.871 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.682 | ||
| DHCR7 | 7-dehydrocholesterol reductase | 0.669 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.429 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.345 | ||
| MED15 | mediator complex subunit 15 | 0.251 | ||
| SC4MOL | sterol-C4-methyl oxidase-like | 0.229 | ||
| AR | androgen receptor | 0.227 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.223 | ||
| RARA | retinoic acid receptor, alpha | 0.206 | ||
| IDI1 | isopentenyl-diphosphate delta isomerase 1 | 0.147 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.144 | ||
| CTDNEP1 | CTD nuclear envelope phosphatase 1 | 0.115 | ||
| INSIG1 | insulin induced gene 1 | 0.106 | ||
| TMEM188 | transmembrane protein 188 | 0.088 | ||
| HTT | huntingtin | 0.052 | ||
| RXRA | retinoid X receptor, alpha | 0.048 | ||
| MED25 | mediator complex subunit 25 | 0.044 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.043 | ||
| PCSK9 | proprotein convertase subtilisin/kexin type 9 | 0.038 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.037 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.036 | ||
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.036 | ||
| TRIM11 | tripartite motif containing 11 | 0.035 | ||
| PSEN1 | presenilin 1 | 0.032 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.031 | ||
| IRF3 | interferon regulatory factor 3 | 0.030 | ||
| EDF1 | endothelial differentiation-related factor 1 | 0.030 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.030 | ||
| JUP | junction plakoglobin | 0.027 | ||
| FOXO3 | forkhead box O3 | 0.025 | ||
| HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | 0.025 | ||
| HIC1 | hypermethylated in cancer 1 | 0.024 | ||
| FOXO1 | forkhead box O1 | 0.022 | ||
| SQLE | squalene epoxidase | 0.019 | ||
| MSTO1 | misato homolog 1 (Drosophila) | 0.019 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.018 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.017 | ||
| FDPS | farnesyl diphosphate synthase | 0.016 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.016 | ||
| UBXN6 | UBX domain protein 6 | 0.015 | ||
| FASN | fatty acid synthase | 0.014 | ||
| LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 0.014 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.013 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.013 | ||
| APOE | apolipoprotein E | 0.013 | ||
| NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | 0.012 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.012 | ||
| LMNA | lamin A/C | 0.011 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.011 | ||
| APOA1 | apolipoprotein A-I | 0.011 | ||
| MVD | mevalonate (diphospho) decarboxylase | 0.011 | ||
| FADS1 | fatty acid desaturase 1 | 0.010 | ||
| DAXX | death-domain associated protein | 0.010 |